.
.
Ključne reči:
.
Sažetak
.
Reference
References
1. Liu XW, Zi Y, Xiang LB, Wang Y. Total hip arthroplasty: areview of advances, advantages and limitations. Int J Clin Exp Med. 2015;8(1):27-36.
2. Supra R, Supra R, Agrawal DK. Surgical Approaches in Total Hip Arthroplasty. J Orthop Sports Med. 2023;5(2):232-40.
3. Dimitriou D, Antoniadis A, Flury A, Liebhauser M, Helmy N. Total Hip Arthroplasty Improves the Quality-Adjusted Life Years in Patients Who Exceeded the Estimated Life Expectancy. J Arthroplasty. 2018;33(11):3484-9.
4. Aggarwal VK, Rasouli MR, Parvizi J. Periprosthetic joint infection: Current concept. Indian J Orthop. 2013;47(1):10-7.
5. Lucenti L, Testa G, Caldaci A, Sammartino F, Cicio C, Ilardo M, et al. Preoperative Risk Factors for Periprosthetic Joint Infection: A Narrative Review of the Literature. Healthcare (Basel). 2024;12(6).
6. Youssef Y, Roschke E, Dietze N, Dahse AJ, Chaberny IF, Ranft D, et al. Early-Outcome Differences between Acute and Chronic Periprosthetic Joint Infections-A Retrospective Single-Center Study. Antibiotics (Basel). 2024;13(3).
7. Xu Y, Huang TB, Schuetz MA, Choong PFM. Mortality, patient-reported outcome measures, and the health economic burden of prosthetic joint infection. EFORT Open Rev. 2023;8(9):690-7.
8. Delsmann MM, Strahl A, Mühlenfeld M, Jandl NM, Beil FT, Ries C, et al. High prevalence and undertreatment of osteoporosis in elderly patients undergoing total hip arthroplasty. Osteoporos Int. 2021;32(8):1661-8.
9. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14:2029-49.
10. Osterhoff G, Morgan EF, Shefelbine SJ, Karim L, McNamara LM, Augat P. Bone mechanical properties and changes with osteoporosis. Injury. 2016;47 Suppl 2(Suppl 2):S11-20.
11. Föger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P. Osteoporosis: Pathophysiology and therapeutic options. Excli j. 2020;19:1017-37.
12. Vrancianu CO, Serban B, Gheorghe-Barbu I, Czobor Barbu I, Cristian RE, Chifiriuc MC, et al. The Challenge of Periprosthetic Joint Infection Diagnosis: From Current Methods to Emerging Biomarkers. Int J Mol Sci. 2023;24(5).
13. Romanò CL, Petrosillo N, Argento G, Sconfienza LM, Treglia G, Alavi A, et al. The Role of Imaging Techniques to Define a Peri-Prosthetic Hip and Knee Joint Infection: Multidisciplinary Consensus Statements. J Clin Med. 2020;9(8).
14. Al-Jabri T, Ridha M, Wood MJ, Kayani B, Jayadev C, McCulloch RA, et al. An overview of the current diagnostic approach to Periprosthetic Joint Infections. Orthop Rev (Pavia). 2024;16:120308.
15. Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018;9:754.
16. Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med. 2013;28(3):285-91.
17. Bitik B, Mercan R, Tufan A, Tezcan E, Küçük H, İlhan M, et al. Differential diagnosis of elevated erythrocyte sedimentation rate and C-reactive protein levels: a rheumatology perspective. Eur J Rheumatol. 2015;2(4):131-4.
18. Wang R, Zhang H, Ding P, Jiao Q. The accuracy of D-dimer in the diagnosis of periprosthetic infections: a systematic review and meta-analysis. J Orthop Surg Res. 2022;17(1):99.
19. Li Y, Min L, Zhang X. Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children. BMC Pulm Med. 2021;21(1):386.
20. Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748-73.
21. Ichise Y, Saegusa J, Tanaka-Natsui S, Naka I, Hayashi S, Kuroda R, et al. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4. Cells. 2020;9(7).
22. Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology (Bethesda). 2013;28(6):391-403.
23. Sack GH, Jr. Serum Amyloid A (SAA) Proteins. Subcell Biochem. 2020;94:421-36.
24. Schindler M, Walter N, Maderbacher G, Sigmund IK, Alt V, Rupp M. Novel diagnostic markers for periprosthetic joint infection: a systematic review. Front Cell Infect Microbiol. 2023;13:1210345.
25. Bocea BA, Roman MD, Ion NCI, Fleaca SR, Mohor CI, Popa DA, et al. Diagnostic Values of Serum Inflammatory Biomarkers after Hip and Knee Arthroplasty in Patients with Periprosthetic Joint Infection. Healthcare (Basel). 2024;12(15).
26. Biedermann L, Bandick E, Ren Y, Tsitsilonis S, Donner S, Müller M, et al. Inflammation of Bone in Patients with Periprosthetic Joint Infections of the Knee. JB JS Open Access. 2023;8(1).
27. Hughes JL, Allen BC, Shaver C. Role of inflammatory markers in the preoperative evaluation of patients undergoing salvage total hip arthroplasty. Proc (Bayl Univ Med Cent). 2022;35(1):10-4.
1. Liu XW, Zi Y, Xiang LB, Wang Y. Total hip arthroplasty: areview of advances, advantages and limitations. Int J Clin Exp Med. 2015;8(1):27-36.
2. Supra R, Supra R, Agrawal DK. Surgical Approaches in Total Hip Arthroplasty. J Orthop Sports Med. 2023;5(2):232-40.
3. Dimitriou D, Antoniadis A, Flury A, Liebhauser M, Helmy N. Total Hip Arthroplasty Improves the Quality-Adjusted Life Years in Patients Who Exceeded the Estimated Life Expectancy. J Arthroplasty. 2018;33(11):3484-9.
4. Aggarwal VK, Rasouli MR, Parvizi J. Periprosthetic joint infection: Current concept. Indian J Orthop. 2013;47(1):10-7.
5. Lucenti L, Testa G, Caldaci A, Sammartino F, Cicio C, Ilardo M, et al. Preoperative Risk Factors for Periprosthetic Joint Infection: A Narrative Review of the Literature. Healthcare (Basel). 2024;12(6).
6. Youssef Y, Roschke E, Dietze N, Dahse AJ, Chaberny IF, Ranft D, et al. Early-Outcome Differences between Acute and Chronic Periprosthetic Joint Infections-A Retrospective Single-Center Study. Antibiotics (Basel). 2024;13(3).
7. Xu Y, Huang TB, Schuetz MA, Choong PFM. Mortality, patient-reported outcome measures, and the health economic burden of prosthetic joint infection. EFORT Open Rev. 2023;8(9):690-7.
8. Delsmann MM, Strahl A, Mühlenfeld M, Jandl NM, Beil FT, Ries C, et al. High prevalence and undertreatment of osteoporosis in elderly patients undergoing total hip arthroplasty. Osteoporos Int. 2021;32(8):1661-8.
9. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14:2029-49.
10. Osterhoff G, Morgan EF, Shefelbine SJ, Karim L, McNamara LM, Augat P. Bone mechanical properties and changes with osteoporosis. Injury. 2016;47 Suppl 2(Suppl 2):S11-20.
11. Föger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P. Osteoporosis: Pathophysiology and therapeutic options. Excli j. 2020;19:1017-37.
12. Vrancianu CO, Serban B, Gheorghe-Barbu I, Czobor Barbu I, Cristian RE, Chifiriuc MC, et al. The Challenge of Periprosthetic Joint Infection Diagnosis: From Current Methods to Emerging Biomarkers. Int J Mol Sci. 2023;24(5).
13. Romanò CL, Petrosillo N, Argento G, Sconfienza LM, Treglia G, Alavi A, et al. The Role of Imaging Techniques to Define a Peri-Prosthetic Hip and Knee Joint Infection: Multidisciplinary Consensus Statements. J Clin Med. 2020;9(8).
14. Al-Jabri T, Ridha M, Wood MJ, Kayani B, Jayadev C, McCulloch RA, et al. An overview of the current diagnostic approach to Periprosthetic Joint Infections. Orthop Rev (Pavia). 2024;16:120308.
15. Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018;9:754.
16. Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med. 2013;28(3):285-91.
17. Bitik B, Mercan R, Tufan A, Tezcan E, Küçük H, İlhan M, et al. Differential diagnosis of elevated erythrocyte sedimentation rate and C-reactive protein levels: a rheumatology perspective. Eur J Rheumatol. 2015;2(4):131-4.
18. Wang R, Zhang H, Ding P, Jiao Q. The accuracy of D-dimer in the diagnosis of periprosthetic infections: a systematic review and meta-analysis. J Orthop Surg Res. 2022;17(1):99.
19. Li Y, Min L, Zhang X. Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children. BMC Pulm Med. 2021;21(1):386.
20. Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748-73.
21. Ichise Y, Saegusa J, Tanaka-Natsui S, Naka I, Hayashi S, Kuroda R, et al. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4. Cells. 2020;9(7).
22. Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology (Bethesda). 2013;28(6):391-403.
23. Sack GH, Jr. Serum Amyloid A (SAA) Proteins. Subcell Biochem. 2020;94:421-36.
24. Schindler M, Walter N, Maderbacher G, Sigmund IK, Alt V, Rupp M. Novel diagnostic markers for periprosthetic joint infection: a systematic review. Front Cell Infect Microbiol. 2023;13:1210345.
25. Bocea BA, Roman MD, Ion NCI, Fleaca SR, Mohor CI, Popa DA, et al. Diagnostic Values of Serum Inflammatory Biomarkers after Hip and Knee Arthroplasty in Patients with Periprosthetic Joint Infection. Healthcare (Basel). 2024;12(15).
26. Biedermann L, Bandick E, Ren Y, Tsitsilonis S, Donner S, Müller M, et al. Inflammation of Bone in Patients with Periprosthetic Joint Infections of the Knee. JB JS Open Access. 2023;8(1).
27. Hughes JL, Allen BC, Shaver C. Role of inflammatory markers in the preoperative evaluation of patients undergoing salvage total hip arthroplasty. Proc (Bayl Univ Med Cent). 2022;35(1):10-4.
Objavljeno
2025/07/31
Broj časopisa
Rubrika
Original paper
Sva prava zadržana (c) 2025 Yongming Sun
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.